🇺🇸 FDA
Patent

US 11969401

Compositions and methods for treating or limiting development of age-related macular degeneration

granted A61KA61K31/165A61K31/198

Quick answer

US patent 11969401 (Compositions and methods for treating or limiting development of age-related macular degeneration) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/165, A61K31/198, A61K31/222, A61K31/343